Cedric Francois - Chief Executive Officer, Apellis Pharmaceuticals, Inc
As of February 14, 2022
Cedric Francois Net Worth
- Net worth is estimated to be at least $52.38M
- Owns at least 1,347,490 units of Apellis Pharmaceuticals, Inc stock
- Sold an estimated value of $6.38M in the last 4 years at Apellis Pharmaceuticals, Inc
Cedric Francois Compensation at Apellis Pharmaceuticals, Inc in 2020
- Earned a $618,769 salary and a $429 bonus
- Rewarded $1,523,844 in stock value and options
- Received a total compensation of $9,275,425
Cedric Francois Trading
- Largest purchase of shares was 61,274 units , worth over $131.13K on March 18, 2020
- Largest sale of shares was 35,638 units , worth over $1.5M on January 17, 2020
- In total has made about 33 transactions over 4 years
- Usually trades in February, with the busiest year in 2020
Cedric Francois
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Cedric Francois Mailing Address
- Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY
Apellis Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Cedric Francois, M.D., Ph.D. | 2020 | $618,769 | $429,687 | $1,523,844 | $6,703,125 | - | $9,275,425 |
| Cedric Francois, M.D., Ph.D. | 2019 | $560,019 | $427,893 | - | $3,279,270 | - | $4,267,182 |
| Cedric Francois, M.D., Ph.D. | 2018 | $550,000 | $381,562 | - | $3,127,600 | $15,378 | $4,074,540 |
| Timothy Sullivan | 2020 | $430,269 | $244,688 | $518,129 | $2,279,063 | $13,000 | $3,485,149 |
| Timothy Sullivan | 2019 | $386,423 | $214,730 | - | $1,108,650 | $9,500 | $1,719,303 |
| Timothy Sullivan | 2018 | $380,000 | $190,000 | - | $279,250 | $10,502 | $859,752 |
| Pascal Deschatelets, Ph.D. | 2020 | $423,500 | $239,062 | $415,594 | $1,828,125 | $11,801 | $2,918,082 |
| Pascal Deschatelets, Ph.D. | 2019 | $404,077 | $252,608 | - | $1,108,650 | $55,893 | $1,821,228 |
| Pascal Deschatelets, Ph.D. | 2018 | $400,000 | $225,000 | - | $1,228,700 | $8,657 | $1,862,357 |
| Nur Nicholson | 2020 | $138,462 | $150,068 | - | $2,648,750 | $84,874 | $3,022,154 |
| Adam Townsend | 2020 | $430,038 | $217,500 | $415,594 | $1,828,125 | $9,750 | $2,901,007 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm
Apellis Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 1,250 units sold on May 17, 2022 by Alec MacHiels worth over $48.98K
- In the last 5 years, insiders at Apellis Pharmaceuticals, Inc sold an estimated value of $41.27M and bought an estimated value of $93.76M
- The most active traders are Federico Grossi, CHIEF MEDICAL OFFICER, Cedric Francois, Chief Executive Officer, and Alec MacHiels, Director
- Insider trading is most common in February, with the busiest year in 2021
Apellis Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||